October 2015


In this Supplement

Advancing the Art of EVAR

One Year Later: How the INCRAFT® AAA Stent Graft System Is Realizing Its Design Promise





Download a PDF of this supplement

Insights From David J. Wilson, President of Cordis Corporation

As Cordis Corporation joins Cardinal Health, the Cordis President reflects on the company’s legacy of innovation and shares goals for the future.

The INCRAFT® AAA Stent Graft System: Clinical Results and Experience

Prof. Giovanni Pratesi outlines the effectiveness of a new-generation device in expanding EVAR applicability using clinical evidence from trials and real-world experience.

By Prof. Giovanni Pratesi

Remarkable Ease of Use in Practice for Patients With Complex Aortic Anatomies to Repair Infrarenal AAAs

Corey L. Teigen, MD, summarizes his firsthand experience with the new ultra-low-profile INCRAFT® AAA Stent Graft System during his participation in the premarket INSPIRATION clinical trial.

By Corey L. Teigen, MD

Novel Features Allow for Treatment of Challenging AAAs in Routine Clinical Practice

Stephen Goode, MBChB, MRCS, FRCR, PhD, explains how ease of use and ultra-low profile benefit his patients and his practice.

By Stephen Goode, MBChB, MRCS(Eng), FRCR, PhD

PEVAR Utilizing the New Ultra- Low Profile in Infrarenal AAAs

Prof. Do and Dr. Makaloski discuss how a device with an ultra-low profile offers advantages to patients and the practice.

By Prof. Dai-Do Do, MD, and Vladimir Makaloski, MD

Placement Accuracy and Customization

Prof. Jose M. Abadal, MD, PhD; Prof. Miguel Araujo, MD; and Prof. Esther Vazquez, MD, discuss their clinical experience using this innovative stent graft system.

By Prof. Jose M. Abadal, MD, PhD; Prof. Miguel Araujo, MD; and Prof. Esther Vazquez, MD

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.